Details for New Drug Application (NDA): 016782
✉ Email this page to a colleague
NDA 016782 describes LITHONATE, which is a drug marketed by Solvay and is included in two NDAs. Additional details are available on the LITHONATE profile page.
The generic ingredient in LITHONATE is lithium citrate. There are fifteen drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the lithium citrate profile page.
The generic ingredient in LITHONATE is lithium citrate. There are fifteen drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the lithium citrate profile page.
Summary for 016782
| Tradename: | LITHONATE |
| Applicant: | Solvay |
| Ingredient: | lithium carbonate |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 016782
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | 300MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
